Skip to main content
Caplight Logo









Bereum Co., Ltd.

Bereum Co., Ltd.

Private
SeoulHealthcare & Life Scienceshttps://bereumpostbiotics.com/html/main.asp

Last Round

Series A

May 9, 2022

Est. Valuation

$43.4M

Total Funding Raised

$7.89M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Bereum Co., Ltd. is a biotechnology company that specializes in the research, development, and manufacturing of postbiotic ingredients for the pharmaceutical, food, and cosmetic industries.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Fashion & Beauty, Advanced Materials

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

postbioticsmicrobiome ingredientsbiotech ingredientsfunctional food ingredientscosmetic raw materialsgut healthOEM servicesODM servicesmicrobiome technutraceutical ingredientsskin microbiomeB2B biotechfermentation engineeringprobiotic alternatives

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Bereum Co., Ltd. Comparables

Compare Bereum Co., Ltd. with similar companies based on industry and business-model similarity.

Bereum Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
HealthBiome Inc.
84%
LactoMason Co., Ltd.
79%
GFC Life Science Co., Ltd.
76%

Bereum Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMay 9, 2022

Bereum Co., Ltd. Investors

Notable investors and investment history

Bereum Co., Ltd. investors
InvestorRounds
DS Asset ManagementSeries A
Life Asset ManagementSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 19, 2026

    Monthly visitors grew 673% MoM, reaching 10.7K.

  • Mar 4, 2026

    Monthly visitors grew 463% MoM to 3.1K.

Bereum Co., Ltd. Filings

Explore SEC and related filing metadata, where available.

Bereum Co., Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Bereum Co., Ltd.'s valuation, stock price, and market status.

Is Bereum Co., Ltd. a public or private company?

Bereum Co., Ltd. is a private company.

What is the current stock price of Bereum Co., Ltd.?

Bereum Co., Ltd. is a private company with no public stock price. Caplight tracks Bereum Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Bereum Co., Ltd. worth (valuation)?

Bereum Co., Ltd.'s valuation is estimated at $43.4M based on funding round data.

Can I buy Bereum Co., Ltd. stock?

Bereum Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Bereum Co., Ltd.'s last funding round?

Bereum Co., Ltd.'s most recent funding round was Series A on May 9, 2022.

Who are the main investors in Bereum Co., Ltd.?

Key investors in Bereum Co., Ltd. include DS Asset Management, Life Asset Management.

Will Bereum Co., Ltd. IPO soon?

No public IPO plans have been announced for Bereum Co., Ltd..

How can I track Bereum Co., Ltd. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Bereum Co., Ltd.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSeoul
Employee Range17
Year Founded2010
Last FundingMay 9, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?